BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home » Authors » Kim Coghill

Articles by Kim Coghill

ImClone, BMS Meet With FDA; Next Steps To Be Determined

Feb. 27, 2002
By Kim Coghill

Inhale Strikes Three Deals For PEG Technology, One On THC

Feb. 27, 2002
By Kim Coghill
Inhale Therapeutic Systems Inc. said Tuesday that it recently signed three collaboration deals for use of its PEG injectable technology, and a fourth using its pulmonary technology. (BioWorld Today)
Read More

ImClone, BMS Meet With FDA; Next Steps To Be Determined

Feb. 27, 2002
By Kim Coghill

House Wants Information From Other Potential ImClone Partners

Feb. 25, 2002
By Kim Coghill
WASHINGTON - A House committee has asked seven pharmaceutical companies that negotiated with ImClone Systems Inc. to partner on Erbitux to turn over documentation and research related to those discussions. (BioWorld Today)
Read More

House Wants Information From Other Potential ImClone Partners

Feb. 25, 2002
By Kim Coghill
WASHINGTON - A House committee has asked seven pharmaceutical companies that negotiated with ImClone Systems Inc. to partner on Erbitux to turn over documentation and research related to those discussions. (BioWorld Today)
Read More

Bush Might Have Final Say On Biotech’s Role In Bioterrorism

Feb. 21, 2002
By Kim Coghill

Bush Might Have Final Say On Biotech’s Role In Bioterrorism

Feb. 21, 2002
By Kim Coghill

Beyond Genomics, DiaDexus To Develop Cancer Markers, Targets

Feb. 20, 2002
By Kim Coghill

Beyond Genomics, DiaDexus To Develop Cancer Markers, Targets

Feb. 20, 2002
By Kim Coghill

Curis Restructuring Includes Cutting Programs, Employees

Feb. 19, 2002
By Kim Coghill
Curis Inc. said it intends to cut employees and expenses as part of its effort to realign research and development programs to focus on signaling pathways and stem cell technology. (BioWorld Today)
Read More
Previous 1 2 … 131 132 133 134 135 136 137 138 139 … 142 143 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 9, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 3, 2026
  • Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

    BioWorld Science
    Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing